New shot aims to block peanut allergy reactions
Disease control
Recruiting now
This early-stage trial tests a new drug called MY006 in healthy adults and people with peanut allergy. The goal is to see if it is safe and how the body processes it. Participants receive one or two shots of the drug or a placebo, and later some will eat peanut in a controlled se…
Phase: PHASE1 • Sponsor: Mabylon AG • Aim: Disease control
Last updated May 13, 2026 16:00 UTC